Aurora Cannabis Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 71 Fair Values set on narratives written by author
ACB Community Narratives
European And Australian Medical Cannabis Markets Will Unlock Enduring Potential
European Cannabis Regulations And Intense Competition Will Hamper Expansion
Global Cannabis Legalization And Medical Integration Will Expand Wellness Markets
European And Australian Medical Cannabis Markets Will Unlock Enduring Potential
View narrativeEuropean Cannabis Regulations And Intense Competition Will Hamper Expansion
View narrativeGlobal Cannabis Legalization And Medical Integration Will Expand Wellness Markets
View narrativeTrending Discussion
No trending discussion available.
Recently Updated Narratives
ACB: Curaleaf Bid And Medical Refocus Will Shape Fairly Valued Outlook
ACB: Medical Refocus And Impairment Charges Will Shape Balanced Outlook
ACB: Medical Focus And Rescheduling Tailwinds Will Drive Future Upside Potential
Snowflake Analysis
Aurora Cannabis Inc. Key Details
About ACB
- Founded
- 2013
- Employees
- 1028
- CEO
- Website
View website
Aurora Cannabis Inc., together with its subsidiaries, engages in the production, distribution, and sale of cannabis products in Canada and internationally. The company offers pharmaceutical-grade cannabis products; and medical and consumer cannabis products. It also provides harvested cannabis, trim, cannabis oils, capsules, edibles, vaporizers, dried and fresh cannabis, cannabis plants, cannabis seeds, edible cannabis, cannabis extracts, flowers, vapes / inhalable extracts, edibles / pastilles, concentrates, and cannabis topicals; and patient counseling and outreach services. Its brand portfolio includes Aurora, Being, CanniMed, CraftPlant, Daily Special, Drift, Greybeard, IndiMed, MedReleaf, Pedanios, San Raf, Tasty’s, Whistler, and WMMC. The company also engages in pharmacy activities. Aurora Cannabis Inc. was founded in 2013 and is headquartered in Edmonton, Canada.